Document is current
Any future updates will be listed below
-
Authors
Röckel, Magdalena
Musella, Luca
Preusse, Corinna
Radke, Josefine
Zimmer, Lisa
Thoms, Kai-Martin
Dimitriou, Florentia
Endres, Matthias
Böhmerle, Wolfgang
Fröhlich, Waltraud
Tayb-Boulahfa, Sami
Leonard-Louis, Sarah
Allenbach, Yves
Berking, Carola
Stenzel, Werner
Knauss, Samuel
Vera, Julio
Heinzerling, Lucie
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 8 September 2024
Accepted: 14 July 2025
First Online: 4 August 2025
Declarations
:
: LH has served as consultant for Roche, Novartis, Curevac, Amgen, BMS, MSD, Pierre Fabre and Sanofi. JV has been reimbursed by Novartis for an invited talk. LZ has served as consultant and has received honoraria from BMS, MSD, Novartis, Pierre Fabre, Sanofi, and Sunpharma and travel support from MSD, BMS, Pierre Fabre, Sanofi, Sunpharma and Novartis, outside the submitted work. The other authors report no disclosures relevant to the manuscript.
: This study was approved by the institutional review boards at the Friedrich-Alexander University Erlangen-Nürnberg (2_20B), the LMU University Hospital Munich (20-1122) and at the Charité –Universitätsmedizin Berlin (EA2/163/17). All research was performed in accordance with the legally binding regulations in Germany and the Declaration of Helsinki for research involving human participants. We obtained informed consent from all participants and/or their legal guardians before handling samples and processing data.
